ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]-L-lysine
C31H36N2O6
532.6 g/mol
Pharmaceutical Intermediate

Fmoc-Lys(Dde)-OH

CAS150629-67-7
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

Fmoc-Lys(Dde)-OH is a protected amino acid derivative used as a building block in solid-phase peptide synthesis. The compound features a fluorenylmethoxycarbonyl (Fmoc) group for N-terminal protection and a Dde group for orthogonal protection of the lysine side chain.

Protected amino acid for peptide synthesisBuilding block for solid-phase peptide synthesis

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Fmoc-Lys(Dde)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.89

(2S)-4-[[1-(4,4-Dimethyl-2,6-dioxocyclohexylidene)ethyl]amino]-2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]butanoic acid

CAS235788-61-1

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.81

N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-lysine

CAS204777-78-6

pharmaceutical intermediate

SimilarStructure SimilarSimilarity 0.72

N-Fmoc-N'-[1-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-2,4-diaminobutyric acid

CAS607366-21-2

pharmaceutical intermediate

ReferenceSame Category

2-Chloro-3-methylbenzoic acid

CAS15068-35-6

pharmaceutical intermediate

ReferenceSame Category

4-tert-Butyl-N-(6-chloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide

CAS150727-06-3

pharmaceutical intermediate

ReferenceSame Category

4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine

CAS150728-13-5

pharmaceutical intermediate

ReferenceSame Category

O1-tert-butyl O3-ethyl cis-4-hydroxypiperidine-1,3-dicarboxylate

CAS150779-92-3

pharmaceutical intermediate

Referencestereoisomer of

Fmoc-D-Lys(Dde)-OH

CAS333973-51-6

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[1-(2-hydroxy-4,4-dimethyl-6-oxocyclohexen-1-yl)ethylideneamino]hexanoic acid

InChIKey

AOHSSQNORWQENF-VWLOTQADSA-N

SMILES

CC(=NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C4=C(CC(CC4=O)(C)C)O

Synonyms (15)
  • FMOC-L-LYS(DDE)-OH
  • Fmoc-L-Lysine(Dde)-OH
  • Fmoc-Lys(Dde)-OH

Sourcing Fmoc-Lys(Dde)-OH?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→